Target intelligence / Profile preview

Dynamin 1 pseudogene 30 (DNM1P30)

Target
DNM1P30
Molecular classification
Other (pseudogene)
01

Overview

Dynamin 1 pseudogene 30 (DNM1P30) is a non-protein coding genomic element classified as a pseudogene, meaning it represents a sequence that resembles the *Dynamin 1* gene but does not produce a functional protein product[4]. Pseudogenes such as DNM1P30 may arise through gene duplication or retrotransposition followed by mutation events that inactivate the gene. DNM1P30 should not be confused with functional dynamin family proteins, which are large GTPases involved in membrane fission and vesicle trafficking[1][5], nor is it considered a receptor, enzyme, transporter, or druggable target. No biological functions, disease roles, biomarkers, or therapeutic interactions have been attributed to DNM1P30 in the current literature[4]. DNM1P30 is clearly distinct from the functional *Dynamin 1* protein (DNM1), which is involved in clathrin-mediated endocytosis and is implicated in neurological disorders[1][2][3][5]. DNM1P30 is not a therapeutic target or molecular entity relevant to pharmacology, and its assignment in target discovery or pharmacological databases would be considered incorrect.

Other names
DNM1DN3-4DNM1DN4-3

Beyond the preview

Go deeper on Dynamin 1 pseudogene 30 (DNM1P30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dynamin 1 pseudogene 30 (DNM1P30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call